Categories
May 28, 2026
As AI simplifies product-building, MR teams must weigh build vs. buy carefully, balancing governance, reliability, and research expertise.
Market Research (MR) has always borrowed from enterprise software, but the pace of this borrowing is now accelerated. Till the early 2000’s, MR was inspired primarily by Enterprise BI features: dashboards, tagging systems, structured metadata. Recently, ChatGPT’s launch made newer conveniences, rapidly available: keyword-based search across transcripts, auto-coding, “ask the dataset” interfaces etc.
Today, MR agencies face pressure to differentiate, the possibility of using AI-assisted coding to build internal tools is indeed tempting. Developers can deliver prototypes faster, which this makes software more affordable.
Yet, before heralding a revolution, it’s worth asking – “What’s the catch here?”.
Code-writing capabilities do not a tool make. Yes, AI can embed new workflows into a tool radically fast. I’ve watched colleagues think, “We live the process, surely we can build the tool!”. Sometimes such optimism works; often not. Post-building, each feature needs security review, integration, monitoring, support, compliance updates and long-term maintenance. So, the build-vs-buy decision in MR is rarely about ‘build’. Instead, it’s about ‘own’: how much operational responsibility your team is willing to carry?
Yes, building is easier today, than it used to be. But, running software for years is not.
MR agencies and their clients have been tempted to become software organizations, since decades. Today, ESOMAR’s industry breakdowns increasingly separate MR services from the ‘Research Software’ sector. Their Global Top Insights Companies 2024 report estimated Research Software’s 2023 turnover at roughly US$56B.
MR workflows can be intricate, episodic and exception-heavy. The range of complexity lies within Quant vs Qual, Open-endeds vs Transcripts, Panels vs Customized etc. MR teams often misunderstand familiarity (with MR complexities) as feasibility; and end up overestimating their ability to build sustainable tools. They imagine that because they understand a workflow they can produce software that will consistently run it.
Planning for such a variety of situations means shouldering ongoing responsibilities. These responsibilities aren’t limited to feature-building; and often determine whether the tool survives real projects and real clients. Take for instance:

So let’s try get this right – Building a tool is not the same as writing code. Large IT projects regularly run over budget and under deliver: research by McKinsey and the University of Oxford on over 5,400 projects found that large IT initiatives run 45% over budget and 7% over time, while delivering 56% less value than predicted.
Even small tools carry hidden costs. Josh Pigford, founder of Baremetrics, put it plainly: “Next thing you know, you’ve spent literally 100s of hours building a tool that’s not core to your business. Hours that really hardly saved you any money. But worse than that, it was hours that weren’t spent making more money by improving your core product”.
Lastly, let’s talk about spiralling buyer expectations. ResTech isn’t a ‘side’ market anymore. Today, the “minimum viable expectation” for MR tools resembles modern SaaS products:
All in all, MR workflows are being productized. And when you build, you inherit the same expectations that your buyers hold SaaS-vendors to.
Here’s the tale of a Frankenstein that outgrew itself…
A mid-sized qualitative agency built an internal “Qual Hub” to solve three pains: scheduling, centralized storage of recordings/stimulus, and need for a simple client portal for sharing highlights. Initially, it was excitedly received by employees and clients alike… Qual researchers stopped hunting across folders, clients loved being handed a single link on a platter, note-taking and archiving became really easy.
Then, reality arrived, one client requirement after another:
This was the cost of becoming “SaaS-like” in a ResTech world. At that point, the agency had to decide : Keep investing and become a software company, or adopt a vendor platform?
Around 26% of the ~56B USD ResTech software has been built by research teams themselves, which suggests that some research leaders do make this transition successfully.
Here’s a pragmatic guide that MR teams can use, when evaluating whether to build:
|
Decision driver |
Build if… |
Buy if… |
|
Differentiation |
Your advantage is truly workflow IP |
Your advantage is research craft + speed |
|
Variability |
Workflow is stable and repeatable |
Every study is bespoke and exception-heavy |
|
Governance burden |
Low sensitivity / internal-only |
Recordings, clients, multi-stakeholder access are the standard expectation |
|
Integrations |
Few, stable API dependencies |
Many vendors, panel partners, shifting APIs |
|
Time horizon |
Multi-year commitment with ownership |
Need value this quarter; can’t staff ownership of tool(s) |
|
Risk tolerance |
You can absorb outages + learning |
Client-facing reliability is non-negotiable |
The key is to be honest about what you won’t do: you won’t…
Success comes when teams accept the limits and plan for longterm tool-ownership.
Admittedly, author-bias creeps in here. I build qualitative research software for living, so my instinct is to lean toward Buying. Even from that seat, I’ve seen internal tools succeed only when they are intentionally scoped and when organizations assign clear ownership and resources for maintenance. What fails is the fantasy that a single project will blossom into a platform or that clients will clamor for what you built as restricted-use solution.
So, we’ve established that the buildversusbuy debate is rarely about code or features. It’s about focus, commitment and tradeoffs. Building internal tools can indeed be a path to differentiation and control, if organizations acknowledge the structural and human costs.
Yes, generative tools can shorten the time from idea to prototype. But they don’t relieve teams of ongoing tool-ownership and maintenance, which grow as code volume, dependencies, and stakeholder expectations compound.
The pressure to choose between build vs buy will only grow, as AI continues to productize MR workflows. A more useful question to pursue then, is: How much responsibility does Insights teams really want to take on? If your advantage is research craft and speed, Buying protects focus. If your advantage is workflow IP, and you’re prepared to staff tool-ownership like a SaaS team would; then Building works better. For many teams today, the most resilient answer is hybrid: buy the platform layer that handles governance and reliability, and build narrowly where you truly differentiate.
Comments
Comments are moderated to ensure respect towards the author and to prevent spam or self-promotion. Your comment may be edited, rejected, or approved based on these criteria. By commenting, you accept these terms and take responsibility for your contributions.
Disclaimer
The views, opinions, data, and methodologies expressed above are those of the contributor(s) and do not necessarily reflect or represent the official policies, positions, or beliefs of Greenbook.
More from Jiten Madia
As AI reshapes research, top Qual experts stand out through adaptability, depth, and judgment—walking with AI, not fearing it, with clarity and intent...
ARTICLES
Restech can save time and money, but underuse leads to wasted value. Learn simple steps to maximize your tech investment and boost renewal success.
Discover the latest innovations and technologies in the restech space amidst industry-wide slowdowns with our market research website.
Consumer segmentation has evolved from traditional demographic methods to more advanced techniques in the digital age, driven by vast data availabilit...
Are you sick of hearing about ChatGPT and generative AI yet? The truth is technology like this is going to keep advancing at record speed, and every i...
Sign Up for
Updates
Get content that matters, written by top insights industry experts, delivered right to your inbox.